SMS Pharmaceuticals Ltd Annually Results

Gross Sales

782.75

709.26

522.05

519.87

563.18

Excise Duty

0

0

0

0

0

Net Sales

782.75

709.26

522.05

519.87

563.18

Other Operating Income

0

0

0

0

0

Other Income

6.22

4.46

4.91

5.2

3.45

Total Income

788.97

713.72

526.97

525.07

566.63

Total Expenditure

643.76

592.64

467.58

405.55

442.07

PBIDT

145.22

121.08

59.39

119.53

124.56

Interest

18.54

23.46

21.91

18.88

11.16

PBDT

126.67

97.62

37.47

100.65

113.4

Depreciation

34.34

31.52

32.13

32.15

22.28

Minority Interest Before NP

0

0

0

0

0

Tax

19.64

15.13

0

14.92

16.05

Deferred Tax

5.3

1.78

1.47

-14.3

14.11

Reported Profit After Tax

67.4

49.2

3.88

67.88

60.96

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

69.14

49.83

-7.06

62.22

62.53

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

69.14

49.83

-7.06

62.22

62.53

EPS (Unit Curr.)

8.16

5.89

-0.83

7.35

7.39

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

40

40

30

30

30

Equity

8.87

8.47

8.47

8.47

8.47

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

18.55

17.07

11.37

22.99

22.11

PBDTM(%)

16.18

13.76

7.17

19.36

20.13

PATM(%)

8.61

6.93

0.74

13.05

10.82